Public Sector Pension Investment Board (PSP Investments)’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,000
Closed -$2.55M 1255
2024
Q2
$2.55M Hold
8,000
0.02% 740
2024
Q1
$1.84M Hold
8,000
0.01% 800
2023
Q4
$1.76M Hold
8,000
0.01% 820
2023
Q3
$1.81M Hold
8,000
0.01% 815
2023
Q2
$1.77M Hold
8,000
0.01% 981
2023
Q1
$1.79M Sell
8,000
-8,000
-50% -$1.97M 0.01% 971
2022
Q4
$4.45M Buy
+16,000
New +$4.04M 0.03% 481
2020
Q3
Sell
-9,316
Closed -$1.13M 1478
2020
Q2
$1.13M Buy
+9,316
New +$1.05M 0.01% 1062
2020
Q1
Sell
-20,156
Closed -$1.77M 1482
2019
Q4
$1.77M Buy
+20,156
New +$1.77M 0.01% 1181
2019
Q1
Sell
-18,600
Closed -$2.03M 1609
2018
Q4
$2.03M Buy
+18,600
New +$2.16M 0.02% 600

Other funds holding UTHR

Public Sector Pension Investment Board (PSP Investments)'s UTHR Position: Q3 2024 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 8,000 shares — an estimated $2.55M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in UTHR in Q4 2018 and held it in 10 quarters. The position peaked at $4.45M in Q4 2022. 625 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 8,000 United Therapeutics shares in Q3 2024, an estimated $2.55M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in United Therapeutics in Q4 2018 and held it in 10 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s United Therapeutics position peaked at $4.45M in Q4 2022.
  • 625 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2024, filed 14 Nov 2024.